Mereo BioPharma Group plc is a clinical-stage biopharmaceutical company focused on rare diseases. Its lead product candidate is setrusumab (BPS-804/UX143), an anti-sclerostin monoclonal antibody being developed for the treatment of osteogenesis imperfecta (OI). The company conducts Phase 3 clinical trials (Orbit and Cosmic studies) and relies on CROs and CMOs for clinical development and manufacturing activities.
expected 2026-11-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-19 | 2025-12-31 | 0001193125-26-115226 | EDGAR | 104K words |
| 2025-03-26 | 2024-12-31 | 0000950170-25-044787 | EDGAR | 103K words |
| 2024-03-27 | 2023-12-31 | 0000950170-24-037348 | EDGAR | 117K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001193125-26-343533 | EDGAR | 19K words |
| 2025-11-10 | 2025-09-30 | 0001193125-25-274272 | EDGAR | 20K words |
| 2025-08-12 | 2025-06-30 | 0001193125-25-178489 | EDGAR | 19K words |
| 2025-05-13 | 2025-03-31 | 0000950170-25-069816 | EDGAR | 15K words |
| 2024-11-12 | 2024-09-30 | 0000950170-24-124637 | EDGAR | 20K words |
| 2024-08-13 | 2024-06-30 | 0000950170-24-095777 | EDGAR | 20K words |
| 2024-05-15 | 2024-03-31 | 0000950170-24-060497 | EDGAR | 16K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-19 | 0001193125-26-356168 | EDGAR | 1K words |
| 2026-08-11 | 0001193125-26-343519 | EDGAR | 3K words |
| 2026-08-11 | 0001193125-26-343482 | EDGAR | 2K words |
| 2026-03-27 | 0001193125-26-127253 | EDGAR | 1K words |
| 2026-03-19 | 0001193125-26-115211 | EDGAR | 3K words |
| 2026-02-17 | 0001193125-26-054787 | EDGAR | 1K words |
| 2026-01-12 | 0001193125-26-009829 | EDGAR | 2K words |
| 2025-12-29 | 0001193125-25-332520 | EDGAR | 2K words |
| 2025-11-10 | 0001193125-25-274319 | EDGAR | 3K words |
| 2025-08-12 | 0000950170-25-106924 | EDGAR | 3K words |
170 total filings indexed. 150 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001719714 |
| Ticker | MREO |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | X0 |
| Website | https://www.mereobiopharma.com |
| Listed | 2018-04-24 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/MREO (~200 tokens, structured JSON with cryptographic provenance)